For the Inventor, By the Inventor

Enter assignee name

New Brunswick, NJ, United States of America

Johnson & Johnson Pharmaceutical Research & Development, LLC

Calculating rank

USPTO Granted Patents = 13

% Expired Patents = 38.5

Forward Citations = 161

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Francis Raymond Salemme (5 out of 30 patents)

Victor S Lobanov (5 out of 11 patents)

Dimitris K Agrafiotis (5 out of 20 patents)

4. Pu Xia (3 out of 4 patents)

5. Stuart Maxwell Pitson (3 out of 4 patents)

6. Brian Wolff Wattenberg (3 out of 4 patents)

7. Jennifer Ruth Gamble (3 out of 4 patents)

8. F Raymond Salemme (2 out of 13 patents)

9. Richard James D'Andrea (2 out of 2 patents)

10. Matthew Alexander Vadas (2 out of 3 patents)

11. Theodore E Carver, Jr (2 out of 4 patents)

12. Scott L Dax (1 out of 50 patents)

13. Wenying Chai (1 out of 31 patents)

14. Dale A Rudolph (1 out of 29 patents)

15. Mark Seierstad (1 out of 12 patents)

13 patents: Sort by Forward Citations

1. 7655756 - Crystallized structure of estrogen related receptor gamma in complex with bisphenol A (2010-02-02),

2. 7416524 - System, method and computer program product for fast and efficient searching of large chemical libraries (2008-08-26),

3. 7317025 - Non-peptidic NPY Y2 receptor inhibitors (2008-01-08),

4. 7188055 - Method, system, and computer program for displaying chemical data (2007-03-06),

5. 7172879 - Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity (2007-02-06),

6. 7139739 - Method, system, and computer program product for representing object relationships in a multidimensional space (2006-11-21),

7. 7122321 - High throughput method for functionally classifying proteins identified using a genomics approach (2006-10-17),

8. 7112427 - Sphingosine kinase enzyme (2006-09-26),

9. 7078406 - Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes (2006-07-18),

10. 7054757 - Method, system, and computer program product for analyzing combinatorial libraries (2006-05-30),

11. 7039621 - System, method, and computer program product for representing object relationships in a multidimensional space (2006-05-02),

12. 6940055 - Microtiter plate with integral heater (2005-09-06),

13. 6730480 - Sphingosine kinase enzyme (2004-05-04),

Company Overview

Johnson & Johnson Pharmaceutical Research & Development, LLC, based in New Brunswick, NJ, is a key player in the global healthcare sector, focusing on the discovery and development of innovative pharmaceuticals. The organization specializes in various therapeutic areas, including immunology, oncology, neuroscience, and infectious diseases. With a commitment to advancing medical science, it employs cutting-edge research methodologies and collaborates with academic institutions and industry partners to bring transformative treatments to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#10 in New Brunswick, NJ

#896 in New Jersey

#23,854 in US

#45,081 in the World

New Brunswick, NJ, United States of America

Johnson & Johnson Pharmaceutical Research & Development, LLC

Forward Citations = 161

35 inventors:

Francis Raymond Salemme (5 out of 30 patents)

Victor S Lobanov (5 out of 11 patents)

Dimitris K Agrafiotis (5 out of 20 patents)

4. Pu Xia (3 out of 4 patents)

5. Stuart Maxwell Pitson (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Johnson & Johnson Pharmaceutical Research & Development, LLC. Retrieved from https://idiyas.com/company/johnson-and-johnson-pharmaceutical-research-and-development

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…